The cardiometabolic diseases market continues to expand steadily as the global burden of chronic conditions such as diabetes, obesity, hypertension, and cardiovascular diseases increases. The global cardiometabolic diseases market size was valued at USD 192.9 billion in 2024 and is expected to reach USD 305.14 billion by 2032, at a CAGR of 5.90% during...